• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Harrow, Inc. - Common Stock (NQ:HROW)

    47.24 -3.80 (-7.45%)
    Streaming Delayed Price Updated: 3:44 PM EST, Jan 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 684,736
    Open 51.00
    Bid (Size) 47.14 (700)
    Ask (Size) 47.34 (300)
    Prev. Close 51.04
    Today's Range 46.82 - 51.06
    52wk Range 20.85 - 54.85
    Shares Outstanding 37,037,453
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    HARROW INC (NASDAQ:HROW) Emerges as a High-Growth Momentum Stock with Strong Technical Setup ↗
    Via Chartmill
    News headline image
    Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% ↗
    Harrow’s accelerating revenue and expanding product portfolio may help explain why a fundamentals-focused investment firm just made it a new position. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -5.3%
    -5.3%
    1 Month
    -2.3%
    -2.3%
    3 Month
    +16.4%
    +16.4%
    6 Month
    +50.6%
    +50.6%
    1 Year
    +30.7%
    +30.7%

    More News

    Read More
    News headline image
    Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside ↗
    Via Stocktwits
    News headline image
    Demystifying Harrow: Insights From 5 Analyst Reviews ↗
    Via Benzinga
    News headline image
    Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever? ↗
    Via Benzinga
    News headline image
    Tesla To Rally Around 4%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
    Via Benzinga
    News headline image
    HARROW INC (NASDAQ:HROW) Presents High Growth Momentum and Technical Breakout Opportunity ↗
    Via Chartmill
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    A Preview Of Harrow's Earnings ↗
    Via Benzinga
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For August 11, 2025 ↗
    Via Benzinga
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
    From Harrow, Inc.
    Via Business Wire
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
    Via Benzinga
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
    Via Benzinga
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
    From Pomerantz LLP
    Via GlobeNewswire

    Frequently Asked Questions

    Is Harrow, Inc. - Common Stock publicly traded?
    Yes, Harrow, Inc. - Common Stock is publicly traded.
    What exchange does Harrow, Inc. - Common Stock trade on?
    Harrow, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Harrow, Inc. - Common Stock?
    The ticker symbol for Harrow, Inc. - Common Stock is HROW on the Nasdaq Stock Market
    What is the current price of Harrow, Inc. - Common Stock?
    The current price of Harrow, Inc. - Common Stock is 47.24
    When was Harrow, Inc. - Common Stock last traded?
    The last trade of Harrow, Inc. - Common Stock was at 01/09/26 03:44 PM ET
    What is the market capitalization of Harrow, Inc. - Common Stock?
    The market capitalization of Harrow, Inc. - Common Stock is 1.75B
    How many shares of Harrow, Inc. - Common Stock are outstanding?
    Harrow, Inc. - Common Stock has 2B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.